Wednesday, March 28, 2012

>VIVIMED LABS: Acquisition of Uquifa Spain and Uquifa Mexico


■ Vivimed Labs Ltd engages in the specialty chemicals & pharmaceuticals businesses in India.

■ During the quarter ended, the robust growth of revenue is increased by 8.20% to Rs.928.50 million.

■ Vivimed Labs Ltd has acquired Uquifa, a 75-year-old manufacturer of pharma

■ APIs and intermediates with operations in Spain and Mexico.

■ Vivimed has offices in India, China, Europe & USA, with manufacturing facilities focused around Hyderabad city in India.

■ Vivimed Labs has floated three overseas subsidiaries, either directly/ through its subsidiary companies.

■ Net Sales and PAT of the company are expected to grow at a CAGR of 32% and 44% over 2010 to 2013E respectively.

To read full report: VIVIMED LABS